联合治疗

#药闻简讯# $联合治疗(UTHR)$ 今日宣布，其评估雾化Tyvaso治疗特发性肺纤维化（IPF）的TETON-1研究达到了主要疗效终点，证明与安慰剂相比，雾化Tyvaso在第52周时绝对用力肺活量（FVC）变化方面具有优势，平均变化为130.1 mL（Hodges-Lehmann [H-L] 估计值，95% 置信区间 [CI]，82.2 至 178.1 mL；p...

#药闻简讯# $联合治疗(UTHR)$ 3 期 ADVANCE OUTCOMES 研究达到了其主要终点，与安慰剂相比，ralinepag 使 PAH 患者发生临床恶化事件的风险降低了 55%（风险比 0.45，95% CI [0.33-0.62]；p<0.0001）。
$云顶新耀(01952)$ 国内权益

United Therapeutics 股价周一（3月30日）大涨近 14%。此前，公司宣布其雾化吸入制剂 Tyvaso（曲前列尼尔/treprostinil）在特发性肺纤维化（IPF）中的第二项Ⅲ期研究 TETON‑1 成功达到主要终点，再次验证了该药物在这一高未满足需求领域的临床潜力。网页链接

$联合治疗(UTHR)$ 屎一般行情中的一抹亮色

在竞争激烈的肺动脉高压（PAH）领域，United Therapeutics 正准备为其产品线再添一枚“重量级筹码”。
在最新 III 期临床数据显示其显著降低疾病恶化风险后，United 宣布计划于今年下半年向 FDA 递交 ralinepag 的上市申请。这款 每日一次口服的前列环素受体激动剂，被公司视为有潜力重塑 PAH ...

$联合治疗(UTHR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001673232-26-000005  Size: 16 KB 网页链接

$联合治疗(UTHR)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0002107022-26-000003  Size: 3 KB 网页链接

$联合治疗(UTHR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0002028640-26-000002  Size: 4 KB 网页链接

$联合治疗(UTHR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001673232-26-000010  Size: 16 KB 网页链接

$联合治疗(UTHR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0002028640-26-000005  Size: 4 KB 网页链接

$联合治疗(UTHR)$ 144 Report of proposed sale of securities Accession Number: 0001950047-26-000809  Act: 33  Size: 23 KB 网页链接

$联合治疗(UTHR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001231589-26-000005  Size: 11 KB 网页链接

$联合治疗(UTHR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001106578-26-000001  Size: 11 KB 网页链接

$联合治疗(UTHR)$ 144 Report of proposed sale of securities Accession Number: 0001950047-26-002033  Act: 33  Size: 14 KB 网页链接

$联合治疗(UTHR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001106578-26-000008  Size: 44 KB 网页链接

$联合治疗(UTHR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001106578-26-000015  Size: 33 KB 网页链接

$联合治疗(UTHR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001673232-26-000013  Size: 16 KB 网页链接

$联合治疗(UTHR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001231589-26-000007  Size: 14 KB 网页链接

$联合治疗(UTHR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001106578-26-000013  Size: 29 KB 网页链接

$联合治疗(UTHR)$ 144 Report of proposed sale of securities Accession Number: 0001950047-26-002703  Act: 33  Size: 8 KB 网页链接